Cost-effectiveness of Primary Screening for CKD: A Systematic Review

Paul Komenda; Thomas W. Ferguson; Kerry Macdonald; Claudio Rigatto; Chris Koolage; Manish M. Sood; Navdeep Tangri

doi:10.1053/j.ajkd.2013.12.012

Keywords

MedicinePopulationKidney diseaseCost effectivenessProteinuriaQuality-adjusted life yearRenal functionIntensive care medicineDiabetes mellitusIncidence (geometry)Internal medicineKidneyEndocrinologyEnvironmental health

Affiliated Institutions

Related Publications

National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

Andrew S. Levey , Josef Coresh , Ethan M. Balk +7 more

Chronic kidney disease is a worldwide public health problem with an increasing incidence and prevalence, poor outcomes, and high cost. Outcomes of chronic kidney disease include...

2003 Annals of Internal Medicine 4573 citations

Chronic Kidney Disease Diagnosis and Management

Teresa K. Chen , Daphne H. Knicely , Morgan E. Grams

Diagnosis, staging, and appropriate referral of CKD by primary care clinicians are important in reducing the burden of CKD worldwide.

2019 JAMA 1568 citations

Epidemiology of chronic kidney disease: an update 2022

Csaba P. Kövesdy

Chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is m...

2022 Kidney International Supplements 2384 citations

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink , Bergur V. Stefánsson , Ricardo Correa‐Rotter +11 more

Among patients with chronic kidney disease, regardless of the presence or absence of diabetes, the risk of a composite of a sustained decline in the estimated GFR of at least 50...

2020 New England Journal of Medicine 4549 citations

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

Muh Geot Wong , Vlado Perkovic , John Chalmers +15 more

OBJECTIVE The Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) trial reported that intensive glucose control prevents end-stage...

2016 Diabetes Care 226 citations

Publication Info

Year: 2014
Type: review
Volume: 63
Issue: 5
Pages: 789-797
Citations: 246
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Cost-effectiveness of Primary Screening for CKD: A Systematic Review

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

246

OpenAlex

Cite This

APA Style

                            
                                
                                    Paul Komenda, 
                                
                                    Thomas W. Ferguson, 
                                
                                    Kerry Macdonald
                                
                                et al.
                            
                            (2014). 
                            Cost-effectiveness of Primary Screening for CKD: A Systematic Review. 
                            American Journal of Kidney Diseases
                            , 63
                            (5)
                            , 789-797.
                            https://doi.org/10.1053/j.ajkd.2013.12.012
                        

Identifiers

DOI: 10.1053/j.ajkd.2013.12.012